Submit Deal

Announced

13 Feb 2024

Completed

15 Feb 2024

Eris Lifesciences completed the acquisition of a 70% stake in Swiss Parenterals for $105m.

Synopsis

Eris Lifesciences, an Indian branded formulations company, completed the acquisition of a 70% stake in Swiss Parenterals, a progressing dynamic pharmaceutical manufacturing company, for $105m.

Principals

target

Swiss Parenterals

bidder

Eris Lifesciences

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (10)

bhakti madan

Senior Associate at Cyril Amarchand Mangaldas

Lawyer

target

Deals

£ 1.53 B

Total Value

lakshmi prakash

Partner at Cyril Amarchand Mangaldas

Lawyer

target

Deals

£ 4.63 B

Total Value

vikram shah

Chairman and Managing Director at SWISS PARENTERALS

Manager

target

Deal

£ 84 M

Total Value

preet choksi

Associate at Cyril Amarchand Mangaldas

Lawyer

target

Deals

£ 260 M

Total Value

ravi shah

Partner at Cyril Amarchand Mangaldas

Lawyer

target

Deals

£ 365 M

Total Value

avani dalal

Principal Associate at Cyril Amarchand Mangaldas

Lawyer

target

Deals

£ 365 M

Total Value

vidhi kotak shah

Associate at Cyril Amarchand Mangaldas

Lawyer

target

Deal

£ 84 M

Total Value

kushal rohira

Principal Associate Designate at Cyril Amarchand Mangaldas

Lawyer

target

Deal

£ 84 M

Total Value

divyansh sharma

Associate at Cyril Amarchand Mangaldas

Lawyer

target

Deal

£ 84 M

Total Value

arushi bindal

Associate at Cyril Amarchand Mangaldas

Lawyer

target

Deals

£ 1.08 B

Total Value

Bidder Team (1)

amit bakshi

Chairman and Managing Director at ERIS LIFESCIENCES

Manager

bidder

Deals

£ 248 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy